TWD
BIIB icon

True Wealth Design’s Biogen BIIB Stock Holding History

True Wealth Design’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78.9K Buy
365
+60
+20% +$11.5K 0.02% 326
2026
Q1 		$55.9K Buy
305
+69
+29% +$12.7K 0.02% 373
2025
Q4 		$41.5K Buy
236
+3
+1% +$490 0.01% 384
2025
Q3 		$32.6K Buy
233
+90
+63% +$12.2K 0.01% 440
2025
Q2 		$18K Buy
143
+118
+472% +$14.7K 0.01% 408
2025
Q1 		$3.42K Sell
25
-49
-66% -$7K ﹤0.01% 806
2024
Q4 		$11.3K Buy
74
+70
+1,750% +$11.8K ﹤0.01% 403
2024
Q3 		$776 Hold
4
– – ﹤0.01% 1023
2024
Q2 		$928 Sell
4
-1
-20% -$217 ﹤0.01% 524
2024
Q1 		$1.08K Buy
5
+2
+67% +$468 ﹤0.01% 449
2023
Q4 		$777 Sell
3
-1
-25% -$246 ﹤0.01% 387
2023
Q3 		$1.03K Hold
4
– – ﹤0.01% 318
2023
Q2 		$1.14K Sell
4
-4
-50% -$1.19K ﹤0.01% 311
2023
Q1 		$2.23K Buy
8
+4
+100% +$1.11K ﹤0.01% 332
2022
Q4 		$1.11K Buy
+4
New +$1.13K ﹤0.01% 332

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

True Wealth Design's BIIB Position: Q2 2026 in Review

True Wealth Design increased its Biogen (BIIB) stake by 20% in Q2 2026, buying an estimated $11.5K and bringing the position to 365 shares worth $78.9K. The position accounts for 0.02% of the portfolio, ranked #326.

True Wealth Design first reported a position in BIIB in Q4 2022 and has held it in 15 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • True Wealth Design held 365 shares of Biogen worth $78.9K as of Q2 2026.
  • True Wealth Design bought 60 Biogen shares in Q2 2026, an estimated $11.5K.
  • Biogen made up 0.02% of True Wealth Design's portfolio in Q2 2026, its #326 holding.
  • True Wealth Design first reported a position in Biogen in Q4 2022 and has held it in 15 quarters since.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.